Heron Therapeutics (HRTX) Misses Q1 EPS by 2c

Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of ($0.70), $0.02 worse than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Target raises full-year sales forecast amid ongoing turnaround drive
• Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance